Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“No End In Sight” For Completing OTC Monographs – CDER Director Woodcock

This article was originally published in The Tan Sheet

Executive Summary

Janet Woodcock says FDA expected when the process was launched to complete all monographs by the year 2000, but 25 remain in tentative final monograph status, with a rulemaking required to finalize each one. “The rulemaking process … doesn’t work for getting monographs done in a very timely manner,” she says.

Advertisement

Related Content

Hatch Closing Act: OTC Monograph Reform Legislation?
Hatch Closing Act: OTC Monograph Reform Legislation?
'Not As Easy' OTC Codeine Label Changes Worry FDA Rx Product Advisors
'Not As Easy' OTC Codeine Label Changes Worry FDA Rx Product Advisors
OTC Monograph Reform Proposal Offers Two-Tier Approach
OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft
OTC Monograph User Fees Totaling $22m To $34m Floated In Senate Discussion Draft
FDA Encourages Novel Switch Ideas, Though NSURE Remains Unsure
CHPA Petitions For Acetaminophen Under-2 Dose Labeling
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off

Topics

Advertisement
UsernamePublicRestriction

Register

PS106814

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel